Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
about
Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMPPhosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin IITargeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1Emerging therapies for pulmonary arterial hypertension.Phosphodiesterase 5 inhibitors augment UT-15C-stimulated ATP release from erythrocytes of humans with pulmonary arterial hypertensionRegulation of cAMP by phosphodiesterases in erythrocytes.PDE1 isozymes, key regulators of pathological vascular remodelingIloprost in pulmonary hypertension.Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1.Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension.Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability.
P2860
Q24336559-FAF95F5F-476D-4DF0-ADE9-96E814353D63Q25255769-47EE5945-9422-4D06-9C3D-5B7681244A6CQ33769656-CC10A643-2EE9-40F4-ACB2-9B12DB400B99Q34252901-EE852E57-2DDE-473C-9449-57D068DE9A07Q34780141-9EA46230-0CF8-45DE-88B9-CED15FF780FCQ36821361-570DBD66-D3A3-4A29-A55D-B0E4D6CB1052Q37070945-555C001C-D145-4656-AACB-1BCD4AEE454CQ37772720-741452AF-1982-4BAF-9037-CCC98B80C5A4Q37941150-115DC244-AE73-427A-83F4-FE2775B3A07FQ43061658-B537DD09-9DCC-4389-9B9F-D571006713FBQ44852804-571663B0-C57C-41BA-85B0-6FD69D4933E5Q46604316-F22F956D-40F8-4E1A-8794-2BFD8CE46DC6Q51085961-E26CA54B-BD03-4342-B1AF-6A73D6AA2567
P2860
Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Lung vasodilatory response to ...... e phosphodiesterase inhibitors
@nl
Lung vasodilatory response to ...... phosphodiesterase inhibitors.
@ast
Lung vasodilatory response to ...... phosphodiesterase inhibitors.
@en
type
label
Lung vasodilatory response to ...... e phosphodiesterase inhibitors
@nl
Lung vasodilatory response to ...... phosphodiesterase inhibitors.
@ast
Lung vasodilatory response to ...... phosphodiesterase inhibitors.
@en
prefLabel
Lung vasodilatory response to ...... e phosphodiesterase inhibitors
@nl
Lung vasodilatory response to ...... phosphodiesterase inhibitors.
@ast
Lung vasodilatory response to ...... phosphodiesterase inhibitors.
@en
P2093
P2860
P50
P356
P1433
P1476
Lung vasodilatory response to ...... phosphodiesterase inhibitors.
@en
P2093
Andreas Weidenbach
Christiane Inholte
Henning Gall
Hossein Ardeschir Ghofrani
P2860
P2888
P356
10.1186/1465-9921-6-76
P407
P577
2005-07-20T00:00:00Z
P5875
P6179
1041714644